Park Y J, Park K S, Kim J H, Shin C S, Kim S Y, Lee H K
Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea.
Clin Endocrinol (Oxf). 1999 Aug;51(2):153-8. doi: 10.1046/j.1365-2265.1999.00773.x.
Previous studies have shown that the rapid ACTH stimulation test using a low dose of 1 microg is more sensitive than that using 250 microg ACTH for detecting subtle cases of adrenal insufficiency. However, there are controversies for the reproducibility of the 1 microg-test. To evaluate the reproducibility of the 1 microg-test, we assessed both day-to-day and diurnal variations of cortisol responses to 1 microg ACTH injection. In addition, optimum sampling time for the 1 microg-test was also determined.
AND DESIGN Eight healthy volunteers and five patients with secondary adrenal insufficiency were recruited. Healthy subjects were given 1 microg ACTH 3 times in the morning (0800 h) and 2 times in the afternoon (1600 h). Patients with adrenal insufficiency had 2-tests in the morning and 2 in the afternoon. Serum cortisol levels were measured every 10 minutes for 1 h after the injection.
In healthy subjects, basal and peak serum cortisol levels were significantly higher in the morning (P < 0.05), whereas maximum cortisol increments were higher in the afternoon (P < 0.001). In patients with adrenal insufficiency, basal and peak serum cortisol levels in the morning were not different from corresponding values in the afternoon. Intra-individual coefficient of variation (CV) of peak serum cortisol response to 1 microg ACTH ranged from 3.0 to 16.4% in healthy subjects and 10.0-34. 4% in patients. Also, there was a significant correlation between peak morning or afternoon cortisol levels after 1 microg ACTH injection given in different days in both healthy subjects and patients. Twenty-six of the 40 studies in healthy subjects showed peak response at 20 minutes, while nine showed it at 30 minutes Using the data acquired at 20 and 30 minutes, all 40 studies in healthy subjects showed normal results while none of 20 studies in patients was normal.
We conclude that the cortisol response to 1 microg ACTH stimulation was reproducible in both healthy subjects and patients with secondary adrenal insufficiency. In order to assess adrenal function more accurately with the 1 microg ACTH stimulation test, serum cortisol should be measured before and 20 and 30 minutes after ACTH injection.
既往研究表明,采用1微克低剂量的快速促肾上腺皮质激素(ACTH)刺激试验在检测肾上腺功能不全的隐匿病例方面比使用250微克ACTH的试验更敏感。然而,1微克试验的可重复性存在争议。为评估1微克试验的可重复性,我们评估了注射1微克ACTH后皮质醇反应的日间和昼夜变化。此外,还确定了1微克试验的最佳采样时间。
招募了8名健康志愿者和5名继发性肾上腺功能不全患者。健康受试者在上午(08:00)接受3次1微克ACTH注射,下午(16:00)接受2次注射。肾上腺功能不全患者在上午和下午各进行2次试验。注射后每10分钟测量血清皮质醇水平,持续1小时。
在健康受试者中,基础和峰值血清皮质醇水平上午显著更高(P < 0.05),而最大皮质醇增量下午更高(P < 0.001)。在肾上腺功能不全患者中,上午的基础和峰值血清皮质醇水平与下午的相应值无差异。健康受试者中,对1微克ACTH的峰值血清皮质醇反应的个体内变异系数(CV)为3.0%至16.4%,患者为10.0%至34.4%。此外,在健康受试者和患者中,不同日期注射1微克ACTH后上午或下午的峰值皮质醇水平之间均存在显著相关性。健康受试者的40项研究中有26项在20分钟时显示峰值反应,9项在30分钟时显示峰值反应。利用在20分钟和30分钟获取的数据,健康受试者的所有40项研究结果均正常,而患者的20项研究均不正常。
我们得出结论,在健康受试者和继发性肾上腺功能不全患者中,对1微克ACTH刺激的皮质醇反应具有可重复性。为了通过1微克ACTH刺激试验更准确地评估肾上腺功能,应在注射ACTH前以及注射后20分钟和30分钟测量血清皮质醇。